Lymphoma Net - Home
Supporting people with non-Hodgkin's lymphoma
Latest news
Nanotechnology may benefit lymphoma patients
30/3/2007
Patients with lymphoma and other cancers may, in the future, benefit from a type of nanotechnology that helps track the growth of tumours and the effectiveness of chemotherapy.
Drug may help reduce risk of graft-versus-host disease
30/3/2007
Researchers have found that treating donor cells with a drug called methotrexate may help reduce the risk of graft-versus-host disease in lymphoma patients who need stem cell transplants.
Chemotherapy type may affect stem cell collection
23/3/2007
The success of stem cell collection for future transplantation in follicular lymphoma patients may depend on the type of chemotherapy they initially receive, researchers have found.
Gene activation may lead to anti-cancer treatment
23/3/2007
Researchers in the UK have developed a new method to destroy cancer cells using a protein, called 37AA, that "kick-starts" an anti-cancer gene.
Treatment hope for primary effusion lymphoma patients
23/3/2007
People with primary effusion lymphoma caused by infection with Kaposi's sarcoma virus may, in the future, benefit from a study conducted by Finnish researchers.
Virus hope for anti-lymphoma treatment
16/3/2007
Researchers in the USA have discovered a way to activate the Epstein-Barr virus inside tumours, providing hope that such viruses can be manipulated to destroy the tumours that they inhabit.
Lymphoma patients to receive 'information prescriptions'
16/3/2007
UK patients with lymphoma and other types of cancer will receive 'information prescriptions' about their disease in a joint initiative by two major cancer charities and the Department of Health.
Breast cancer patients with history of lymphoma "under-treated"
9/3/2007
The treatment of women with breast cancer who have a history non-Hodgkin's lymphoma or Hodgkin's disease needs to be improved, say researchers, who found that these women often fair worse than breast cancer patients without a history of these other cancers.
Childhood cancer survivors at increased risk of bone fractures
9/3/2007
Children who have been successfully treated for lymphoma, leukaemia or other cancers may face an increased risk of bone fractures in later life, say researchers.
Radiotherapy offers no extra benefits for some elderly lymphoma patients
9/3/2007
Radiotherapy has been shown not to provide additional benefits for elderly patients with early but aggressive non-Hodgkin's lymphoma who are receiving CHOP chemotherapy, researchers have found.
Hope for lymphoma prevention in transplant patients
16/2/2007
Study results suggest that a treatment used to protect against herpes-related infection may also protect against the early development of non-Hodgkin's lymphoma in patients who have undergone kidney transplants.
Experimental drug shows promise for leukaemia patients
16/2/2007
An experimental drug, called oblimersen, may benefit patients with chronic lymphocytic leukaemia who have relapsed after initial treatment by increasing their sensitivity to chemotherapy, researchers have found.
Protein study may benefit leukaemia patients
9/2/2007
UK researchers hope to find out whether measuring levels of a particular protein that switches genes on and off in leukaemia cells can be used to predict the best course of treatment for patients with chronic lymphocytic leukaemia.
Study may lead to improved lymphoma treatment
9/2/2007
A study being conducted by scientists at the University of Nottingham in the UK may help improve the effectiveness of treatment for people with non-Hodgkin’s lymphoma.
Hairy cell leukaemia patients at risk of second cancers
9/2/2007
People with a rare type of cancer called hairy cell leukaemia may be at increased risk of developing a second cancer, such as non-Hodgkin’s lymphoma, US researchers have found.
Tool may help identify depression in advanced lymphoma patients
2/2/2007
A new tool for detecting depression in patients with advanced lymphomas and other cancers that have started to spread may improve their quality of life, claim UK researchers.
Injection could replace infusions for lymphocytic leukaemia patients
2/2/2007
Results of a US study indicate that time-consuming antibody infusion therapy for diseases such as chronic lymphocytic leukaemia could be replaced by an injection that can be delivered quickly by a doctor.
European law may improve cancer treatment for children
26/1/2007
The introduction of a new European law means that all children with leukaemia, lymphoma and other types of cancer will have better access to cancer treatments, say campaigners.
Arthritis strongly linked to lymphoma subtype
26/1/2007
Results of a Swedish study show that the increased risk of non-Hodgkin's lymphoma associated with rheumatoid arthritis is particularly pronounced for a subtype of NHL called non-germinal centre diffuse large B cell lymphoma.
New guidelines help doctors assess lymphoma treatment
26/1/2007
An international team of cancer experts has developed a revised, standard set of guidelines for helping doctors assess how well their patients respond to various lymphoma treatments.
Growth factor drug may increase bone loss
19/1/2007
A type of medication called granulocyte colony-stimulating factor, which is used to reduce the toxic side effects of chemotherapy, may decrease bone mineral density and increase the risk of bone tumours, say US researchers.
Allergies not linked to NHL
19/1/2007
Results of a Scandinavian study indicate that contrary to previous belief, allergic diseases such as a hayfever do not influence an individual's risk of developing non-Hodgkin's lymphoma.
Many people think cancer is down to 'fate'
12/1/2007
Results of a UK survey indicate that many people believe their risk of developing cancer is a question of 'fate', and do not realise that their risk can be reduced through lifestyle changes.
Obesity plays 'minor role' in rising lymphoma rates
12/1/2007
Results of a Norwegian study suggest that the significant rise in obesity over recent decades makes only a small contribution to increasing incidence of lymphoma and other "blood cancers".
Drug may benefit elderly patients with DLBCL
12/1/2007
Results of an Italian study suggest that the drug ibritumomab tiuxetan, when given after chemotherapy, may have significant benefits for elderly patients with diffuse large-B-cell lymphoma.
Drug combination benefits CLL patients
5/1/2007
Results of a US study suggest that treatment with a combination of the chemotherapy drugs pentostatin, cyclophosphamide and rituximab may have significant benefits for patients with previously untreated chronic lymphocytic leukaemia.
Non-Hodgkin's lymphoma linked to kidney transplantation
5/1/2007
Patients who have undergone kidney transplantation face a significantly increased risk of developing certain types of cancer including non-Hodgkin's lymphoma, results of an Australian study show.
Diet during pregnancy may affect cancer risk in offspring
29/12/2006
Results of a US study suggest that a mother's diet during pregnancy may affect her child's risk of developing cancer in later life.
Regulator of aggressive B-CLL gene discovered
29/12/2006
The gene responsible for the most aggressive form of B-cell chronic lymphocytic leukaemia appears to be regulated by two microRNAs, a type of protein that could offer novel avenues for treatment, US study findings suggest.
Epstein-Barr virus reduces peripheral T-cell lymphoma survival
29/12/2006
People with peripheral T-cell lymphoma who are infected with Epstein-Barr virus have reduced overall survival in comparison with uninfected patients, particularly in the first 2 years after diagnosis, French researchers have discovered.
Drug combination benefits CLL patients
5/1/2007
Results of a US study suggest that treatment with a combination of the chemotherapy drugs pentostatin, cyclophosphamide and rituximab may have significant benefits for patients with previously untreated chronic lymphocytic leukaemia.
Non-Hodgkin's lymphoma linked to kidney transplantation
5/1/2007
Patients who have undergone kidney transplantation face a significantly increased risk of developing certain types of cancer including non-Hodgkin's lymphoma, results of an Australian study show.
Diet during pregnancy may affect cancer risk in offspring
29/12/2006
Results of a US study suggest that a mother's diet during pregnancy may affect her child's risk of developing cancer in later life.
Regulator of aggressive B-CLL gene discovered
29/12/2006
The gene responsible for the most aggressive form of B-cell chronic lymphocytic leukaemia appears to be regulated by two microRNAs, a type of protein that could offer novel avenues for treatment, US study findings suggest.
Epstein-Barr virus reduces peripheral T-cell lymphoma survival
29/12/2006
People with peripheral T-cell lymphoma who are infected with Epstein-Barr virus have reduced overall survival in comparison with uninfected patients, particularly in the first 2 years after diagnosis, French researchers have discovered.
Tipifarnib shows promise in lymphoma patients
22/12/2006
Results of a US study suggest that treatment with a drug called tipifarnib may benefit patients with relapsed, aggressive non-Hodgkin's lymphoma.
Rituximab approved for Scottish lymphoma patients
22/12/2006
The drug rituximab has been made available as a 'maintenance' therapy for NHS patients in Scotland with follicular lymphoma who have relapsed.
Many cancer patients face financial hardship
15/12/2006
Results of a UK survey indicate that around 6% of people lose their home after being diagnosed with cancer, while 18% struggle to pay their mortgage or rent.
Protein may help prevent graft-versus-host disease in lymphoma patients
15/12/2006
Researchers are to study whether a naturally occurring antibiotic protein can reduce the risk of graft-versus-host disease in patients with lymphoma and other types of blood cancer who undergo bone marrow transplants, also known as haematopoietic stem cell transplants.
Rituximab improves survival in follicular NHL patients
15/12/2006
The addition of the drug rituximab to chemotherapy significantly prolongs the lives of patients with follicular non-Hodgkin's lymphoma, compared with chemotherapy alone, study results show.
Diet during pregnancy may affect cancer risk in offspring
29/12/2006
Results of a US study suggest that a mother's diet during pregnancy may affect her child's risk of developing cancer in later life.
Regulator of aggressive B-CLL gene discovered
29/12/2006
The gene responsible for the most aggressive form of B-cell chronic lymphocytic leukaemia appears to be regulated by two microRNAs, a type of protein that could offer novel avenues for treatment, US study findings suggest.
Epstein-Barr virus reduces peripheral T-cell lymphoma survival
29/12/2006
People with peripheral T-cell lymphoma who are infected with Epstein-Barr virus have reduced overall survival in comparison with uninfected patients, particularly in the first 2 years after diagnosis, French researchers have discovered.
Tipifarnib shows promise in lymphoma patients
22/12/2006
Results of a US study suggest that treatment with a drug called tipifarnib may benefit patients with relapsed, aggressive non-Hodgkin's lymphoma.
Rituximab approved for Scottish lymphoma patients
22/12/2006
The drug rituximab has been made available as a 'maintenance' therapy for NHS patients in Scotland with follicular lymphoma who have relapsed.
Many cancer patients face financial hardship
15/12/2006
Results of a UK survey indicate that around 6% of people lose their home after being diagnosed with cancer, while 18% struggle to pay their mortgage or rent.
Protein may help prevent graft-versus-host disease in lymphoma patients
15/12/2006
Researchers are to study whether a naturally occurring antibiotic protein can reduce the risk of graft-versus-host disease in patients with lymphoma and other types of blood cancer who undergo bone marrow transplants, also known as haematopoietic stem cell transplants.
Rituximab improves survival in follicular NHL patients
15/12/2006
The addition of the drug rituximab to chemotherapy significantly prolongs the lives of patients with follicular non-Hodgkin's lymphoma, compared with chemotherapy alone, study results show.
Further evidence supports no link between mobile phones and cancer
8/12/2006
Results of study conducted in Denmark provide further evidence that the use of mobile phones is not associated with an increased risk of cancer.
Lenalidomide may benefit patients with relapsed CLL
8/12/2006
Patients with chronic lymphocytic leukemia who have relapsed or who no longer respond to chemotherapy, may benefit from treatment with the drug lenalidomide, results of a US study suggest.
Increased chemotherapy times may reduce heart risks
24/11/2006
A review of published studies suggests that extending infusion times for chemotherapy to 6 hours or longer may help reduce the risk of heart problems associated with cancer drugs called anthracyclines.
ER-CHOP 'effective' for newly diagnosed DLBCL patients
24/11/2006
Chemotherapy that combines the drugs epratuzumab and rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone is an effective and well-tolerated treatment for patients who have been newly diagnosed with diffuse large B-cell lymphoma, results of an initial study suggest.
Rituximab improves survival in follicular NHL patients
17/11/2006
Study results show that maintenance therapy with the drug rituximab may significantly improve the overall survival rates of patients with follicular non-Hodgkin's lymphoma who have either relapsed or failed to respond to previous treatment.
Firefighters at increased risk of lymphoma
17/11/2006
Firefighters have a higher risk of developing non-Hodgkin's lymphoma and three other types of cancer than the general population, results of a US study suggest.
Biologic arthritis drugs 'do not increase risk of lymphoma'
17/11/2006
Drugs called "biologics" do not increase the risk of non-Hodgkin's lymphoma among people with rheumatoid arthritis, research findings show.
Infection with Hepatitis C virus linked to lymphoma development
10/11/2006
Results of a German study indicate that long-term infection with the hepatitis C virus may be associated with an increased risk of lymphomas, particularly diffuse large B-cell lymphoma.
Complementary medicine use widespread among cancer patients
10/11/2006
The use of complementary and alternative medicine is common among patients with lymphoma and other forms of cancer, say researchers who stress that doctors should make sure their patients know about the potential risks of combining such treatments with cancer therapy.
Radiotherapy increases second cancer risk for children
3/11/2006
Children who received radiotherapy for cancer face an increased risk of brain and spinal column tumours in later years, results of a US study show.
IL-12 shows promise for patients with mycosis fungoides
3/11/2006
Results of a US study suggest that treatment with interleukin-12 may benefit some patients with a type of skin lymphoma called mycosis fungoides that has not responded to previous therapies.
Mobile phones 'do not increase NHL risk'
3/11/2006
There is no evidence to suggest that the use of mobile phones is associated with an increased risk of non-Hodgkin's lymphoma, say researchers.
Infection with Hepatitis C virus linked to lymphoma development
10/11/2006
Results of a German study indicate that long-term infection with the hepatitis C virus may be associated with an increased risk of lymphomas, particularly diffuse large B-cell lymphoma.
Complementary medicine use widespread among cancer patients
10/11/2006
The use of complementary and alternative medicine is common among patients with lymphoma and other forms of cancer, say researchers who stress that doctors should make sure their patients know about the potential risks of combining such treatments with cancer therapy.
Radiotherapy increases second cancer risk for children
3/11/2006
Children who received radiotherapy for cancer face an increased risk of brain and spinal column tumours in later years, results of a US study show.
IL-12 shows promise for patients with mycosis fungoides
3/11/2006
Results of a US study suggest that treatment with interleukin-12 may benefit some patients with a type of skin lymphoma called mycosis fungoides that has not responded to previous therapies.
Mobile phones 'do not increase NHL risk'
3/11/2006
There is no evidence to suggest that the use of mobile phones is associated with an increased risk of non-Hodgkin's lymphoma, say researchers.
Genetic testing may help predict response to cancer treatment
27/10/2006
The activity of certain gene combinations in tumour samples taken from cancer patients could help identify what type of chemotherapy will be most effective, preliminary results of a US study suggest.
Early anaemia treatment improves quality of life for cancer patients
27/10/2006
Results of a US study suggest that the early treatment of mild anaemia with the drug epoetin alfa, which stimulates the production of red blood cells, can significantly improve the quality of life of patients undergoing chemotherapy for non-Hodgkin’s lymphoma and other blood cancers.
Ankylosing spondylitis 'not linked to increased risk of lymphomas'
20/10/2006
People with ankylosing spondylitis, an arthritis-like inflammatory disease that affects the spinal joints, do not appear to have an increased risk of developing lymphomas, results of a Swedish study show.
Intake of certain nutrients may influence NHL risk
20/10/2006
An international team of researchers discovered that the consumption of certain nutrients may influence an individual's risk of developing non-Hodgkin's lymphoma.
Computer factory workers face increased risk of cancer
20/10/2006
Employees who work in computer manufacturing are at an increased risk of developing non-Hodgkin's lymphoma and other types of cancer, results of a large US study suggest.
Education may improve pain control for cancer patients
8/9/2006
Results of a Canadian study suggest that a simple education program may help improve pain control for patients receiving radiotherapy for cancer.
Epstein-Barr virus protein clue to lymphoma development
8/9/2006
Researchers have identified how a protein produced by the Epstein-Barr virus allows cancers to grow, a finding that could lead to the development of new drugs to destroy cancers caused by the virus.

News Service Provided by Current Medicine Group


 

How useful did you find the information on this page?

Not useful Useful

News Service Provided by Current Medicine Group


 

How useful did you find the information on this page?

Not useful Useful


Legal statement